Literature DB >> 2837973

Metabolism and analysis of endogenous cysteinyl leukotrienes.

D Keppler1, M Huber, W Hagmann, H A Ball, A Guhlmann, S Kästner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2837973     DOI： 10.1111/j.1749-6632.1988.tb38531.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  8 in total

1.  Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro.

Authors:  M N Samhoun; D M Conroy; P J Piper
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

Review 2.  [The Heinrich-Wieland Prize presentation. Metabolism and analysis of leukotrienes in vivo].

Authors:  D Keppler
Journal:  Klin Wochenschr       Date:  1988-10-17

3.  SSIEM Award. Impaired metabolism of leukotrienes in inherited metabolic disorders.

Authors:  E Mayatepek; G F Hoffmann
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

4.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

5.  Leukotrienes in the sputum and urine of cystic fibrosis children.

Authors:  A P Sampson; D A Spencer; C P Green; P J Piper; J F Price
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

6.  Prevention of endogenous leukotriene production during anaphylaxis in the guinea pig by an inhibitor of leukotriene biosynthesis (MK-886) but not by dexamethasone.

Authors:  A Guhlmann; A Keppler; S Kästner; H Krieter; U B Brückner; K Messmer; D Keppler
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

Review 7.  Hepatic circulation: potential for therapeutic intervention.

Authors:  F Ballet
Journal:  Pharmacol Ther       Date:  1990       Impact factor: 12.310

8.  Enhanced levels of leukotriene B(4) in synovial fluid in Lyme disease.

Authors:  E Mayatepek; D Hassler; M Maiwald
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.